Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of OCV-501 in elderly patients with acute myeloid leukemia in first complete remission
jRCT2080222379Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2014
- Modality
- Vaccines & Immunotherapeutics, Peptides
01
Overview
Phase 2, randomised, double-blind trial in acute myeloid leukemia (AML) comparing OCV-501 with Placebo (2 arms). Started Jan 2014; status: completed.
02
Drugs
OCV-501
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on jRCT2080222379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222379.